Developing imaging techniques for Alzheimer's and related diseases
Center without Walls for Imaging Proteinopathies with PET
This study is working on new imaging methods to help doctors see certain proteins linked to Alzheimer's and similar conditions, which could lead to better ways to diagnose and treat these diseases for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10940630 on NIH RePORTER |
What this research studies
This research focuses on creating advanced imaging techniques using Positron Emission Tomography (PET) to visualize specific proteins associated with Alzheimer's disease and related dementias. By developing new PET ligands, the project aims to improve the ability to detect and understand the progression of these neurodegenerative conditions. The collaborative effort involves multiple prestigious institutions, bringing together experts in neurobiology and radiotracer development to enhance diagnostic capabilities. Patients may benefit from improved diagnostic tools that can lead to better-targeted treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals experiencing cognitive decline or those diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients with other forms of dementia not related to Alzheimer's or those without cognitive symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnoses of Alzheimer's disease and related dementias, ultimately improving patient care.
How similar studies have performed: Previous research has shown promise in using PET imaging for neurodegenerative diseases, indicating that this approach has the potential for significant advancements.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Mach, Robert H — University of Pennsylvania
- Study coordinator: Mach, Robert H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.